Carl Wibom

Delprojektledare för forskningsplattformen PREDICT med fokus på datahantering.

Kontakt

Verksam som

Staff scientist vid Institutionen för diagnostik och intervention Enhet: Onkologi

Målpunkt M31, Byggnad 6M, plan 3, Norrlands universitetssjukhus, Translationellt forskningscentrum (TRC) Umeå universitet, 901 85 Umeå

Prediagnostic serum immune marker levels and multiple myeloma: a prospective longitudinal study using samples from the Janus serum bank in Norway

Cancer Prevention Research, American Association For Cancer Research (AACR) 2025, Vol. 18, (7) : 383-391

Sterbova, Simona; Wibom, Carl; Krop, Esmeralda J.M.; et al.

Low-grade glioma risk SNP rs11706832 is associated with type I interferon response pathway genes in cell lines

Scientific Reports, Springer Nature 2023, Vol. 13

Rosenbaum, Adam; Dahlin, Anna M.; Andersson, Ulrika; et al.

Distinct metabolic hallmarks of WHO classified adult glioma subtypes

Neuro-Oncology, Oxford University Press 2022, Vol. 24, (9) : 1454-1468

Björkblom, Benny; Wibom, Carl; Eriksson, Maria; et al.

Assessment of the genetic and clinical determinants of hip fracture risk: Genome-wide association and Mendelian randomization study

Cell Reports Medicine, Elsevier 2022, Vol. 3, (10)

Nethander, Maria; Coward, Eivind; Reimann, Ene; et al.

Robusta biomarkörer för prediktion av risk och sjukdom: en utvärdering av reproducerbarheten hos de stora kommersiella omik-plattformarna

Umeå universitet 2022

Rentoft, Matilda; Melin, Beatrice S.; Wibom, Carl; et al.

Prediagnostic biomarkers for early detection of glioma: using case-control studies from cohorts as study approach

Neuro-Oncology Advances, Oxford University Press 2022, Vol. 4 : II73-II80

Wu, Wendy Yi-Ying; Dahlin, Anna M.; Wibom, Carl; et al.

Pre-diagnostic levels of sVEGFR2, sTNFR2, sIL-2Rα and sIL-6R are associated with glioma risk: A nested case–control study of repeated samples

Cancer Medicine, John Wiley & Sons 2022, Vol. 11, (4) : 1016-1025

Wu, Wendy Yi-Ying; Späth, Florentin; Wibom, Carl; et al.

Intraindividual long-term immune marker stability in plasma samples collected in median 9.4 Years apart in 304 adult cancer-free individuals

Cancer Epidemiology, Biomarkers and Prevention, Philadephia: American Association for Cancer Research 2021, Vol. 30, (11) : 2052-2058

Späth, Florentin; Wu, Wendy Yi-Ying; Krop, Esmeralda J.M.; et al.

A genome-wide association study on medulloblastoma

Journal of Neuro-Oncology, Springer 2020, Vol. 147, (2) : 309-315

Dahlin, Anna M.; Wibom, Carl; Andersson, Ulrika; et al.

The association between longer relative leukocyte telomere length and risk of glioma is independent of the potentially confounding factors allergy, BMI, and smoking

Cancer Causes and Control, Springer 2019, Vol. 30, (2) : 177-185

Andersson, Ulrika; Degerman, Sofie; Dahlin, Anna M.; et al.

Genetic Variants in the 9p21.3 Locus Associated with Glioma Risk in Children, Adolescents, and Young Adults: A Case-Control Study

Cancer Epidemiology, Biomarkers and Prevention, American Association for Cancer Research 2019, Vol. 28, (7) : 1252-1258

Dahlin, Anna M.; Wibom, Carl; Andersson, Ulrika; et al.

A geographically matched control population efficiently limits the number of candidate disease-causing variants in an unbiased whole-genome analysis

PLOS ONE, Public Library of Science 2019, Vol. 14, (3)

Rentoft, Matilda; Svensson, Daniel; Sjödin, Andreas; et al.

Immune marker changes and risk of multiple myeloma: a nested case-control study using repeated prediagnostic blood samples

Haematologica, Ferrata Storti Foundation 2019, Vol. 104, (12) : 2456-2464

Späth, Florentin; Wibom, Carl; Krop, Esmeralda; et al.

The Genetic Architecture of Gliomagenesis-Genetic Risk Variants Linked to Specific Molecular Subtypes

Cancers, MDPI 2019, Vol. 11, (12)

Wu, Wendy Yi-Ying; Johansson, Gunnar; Wibom, Carl; et al.

Biomarker Dynamics in B-cell Lymphoma: A Longitudinal Prospective Study of Plasma Samples Up to 25 Years before Diagnosis

Cancer Research, American Association for Cancer Research 2017, Vol. 77, (6) : 1408-1415

Späth, Florentin; Wibom, Carl; Krop, Esmeralda J. M.; et al.

Metabolomic screening of pre-diagnostic serum samples identifies association between alpha- and gamma-tocopherols and glioblastoma risk

Oncotarget, Vol. 7, (24) : 37043-37053

Björkblom, Benny; Wibom, Carl; Jonsson, Pär; et al.

Relation between Established Glioma Risk Variants and DNA Methylation in the Tumor

PLOS ONE, Public library science 2016, Vol. 11, (10)

Dahlin, Anna M.; Wibom, Carl; Ghasimi, Soma; et al.

Genetic risk variants in the CDKN2A/B, RTEL1 and EGFR genes are associated with somatic biomarkers in glioma

Journal of Neuro-Oncology, Vol. 127, (3) : 483-492

Ghasimi, Soma; Wibom, Carl; Dahlin, Anna M.; et al.

Characterization of the serum metabolome following radiation treatment in patients with high-grade gliomas

Radiation Oncology, BioMed Central 2016, Vol. 11

Mörén, Lina; Wibom, Carl; Bergström, Per; et al.

Pre-diagnostic serum levels of EGFR and ErbB2 and genetic glioma risk variants: a nested case-control study

Tumor Biology, Vol. 37, (8) : 11065-11072

Späth, Florentin; Andersson, Ulrika; Dahlin, Anna M.; et al.

CCND2, CTNNB1, DDX3X, GLI2, SMARCA4, MYC, MYCN, PTCH1, TP53, and MLL2 gene variants and risk of childhood medulloblastoma

Journal of Neuro-Oncology, Vol. 125, (1) : 75-78

Dahlin, Anna M.; Hollegaard, Mads V.; Wibom, Carl; et al.

Investigation of Established Genetic Risk Variants for Glioma in Prediagnostic Samples from a Population-Based Nested Case-Control Study

Cancer Epidemiology, Biomarkers and Prevention, Vol. 24, (5) : 810-816

Wibom, Carl; Späth, Florentin; Dahlin, Anna M.; et al.

Whole-genome sequencing identifies EN1 as a determinant of bone density and fracture

Nature, Vol. 526, (7571) : 112-+

Zheng, Hou-Feng; Forgetta, Vincenzo; Hsu, Yi-Hsiang; et al.

Germline rearrangements in families with strong family history of glioma and malignant melanoma, colon, and breast cancer

Neuro-Oncology, Oxford University Press 2014, Vol. 16, (10) : 1333-1340

Andersson, Ulrika; Wibom, Carl; Cederquist, Kristina; et al.

Glioma Gwas Hits - Markers for Risk or for Prognosis?

Neuro-Oncology, Oxford University Press 2014, Vol. 16, (Suppl. 2) : ii109-ii110

Wibom, Carl; Spaeth, Florentin; Dahlin, Anna; et al.

Genome-wide association study meta-analysis identifies the SOAT1/AXDND1 locus to be associated with hip and forearm fracture risk

Bone Abstracts

Pettersson-Kymmer, Ulrika; Lacroix, Andrea; Eriksson, Joel; et al.

Synergistic killing of Glioblastoma Stem-like cells by Bortezomib and HDAC Inhibitors

Anticancer Research, International Institute of Anticancer Research 2012, Vol. 32, (7 ; Special Issue) : 2407-2413

Asklund, Thomas; Kvarnbrink, Samuel; Holmlund, Camilla; et al.

Synergistic Killing of Glioblastoma Stem-like Cells by Bortezomib and HADC Inhibitors.

Anticancer Research, Vol. 32, (7) : 2407-2413

Asklund, Thomas; Kvarnbrink, Samuel; Holmlund, Camilla; et al.

EGFR gene variants are associated with specific somatic aberrations in glioma

Neuro-Oncology, Vol. 14, (Suppl. 3) : 46-46

Wibom, Carl; Ghasimi, Soma; Van Loo, P.; et al.

EGFR gene variants are associated with specific somatic aberrations in glioma

PLOS ONE, plosone.org 2012, Vol. 7, (12) : e47929-

Wibom, Carl; Ghasimi, Soma; Van Loo, Peter; et al.

DNA-repair gene variants are associated with glioblastoma survival

Acta Oncologica, Informa Healthcare 2012, Vol. 51, (3) : 325-332

Wibom, Carl; Sjöström, Sara; Henriksson, Roger; et al.

Analysis of DNA repair gene polymorphisms and survival in low-grade and anaplastic gliomas

Journal of Neuro-Oncology, Vol. 105, (3) : 531-538

Berntsson, Shala Ghaderi; Wibom, Carl; Sjöström, Sara; et al.

Genetic variations in VEGF and VEGFR2 and glioblastoma outcome

Journal of Neuro-Oncology, Boston: Nijhoff 2011, Vol. 104, (2) : 523-527

Sjöström, Sara; Wibom, Carl; Andersson, Ulrika; et al.

Vandetanib alters the protein pattern in malignant glioma and normal brain in the BT4C rat glioma model

International Journal of Cancer, Vol. 37, (4) : 879-890

Wibom, Carl; Sandström, Maria; Henriksson, Roger; et al.

Metabolomic patterns in glioblastoma and changes during radiotherapy: a clinical microdialysis study

Journal of Proteome Research, American Chemical Society (ACS) 2010, Vol. 9, (6) : 2909-2919

Wibom, Carl; Surowiec, Izabella; Mörén, Lina; et al.

Multivariate analyses of proteomic and metabolomic patterns in brain tumors

Umeå University medical dissertations, 1281

Wibom, Carl

Proteomic profiles differ between bone invasive and noninvasive benign meningiomas of fibrous and meningothelial subtype

Journal of Neuro-Oncology, Springer Netherlands 2009, Vol. 94, (3) : 321-331

Wibom, Carl; Mörén, Lina; Aarhus, Mads; et al.

Cutaneous and mucosal human papillomaviruses differ in net surface charge, potential impact on tropism.

Virology Journal, Vol. 5 : 118-

Mistry, Nitesh; Wibom, Carl; Evander, Magnus

Proteomic Analysis of Malignant Glioma Tissue Following Treatment with the Receptor Tyrosine Kinase Inhibtor ZD6474

Neuro-Oncology : -

Wibom, C; Sandström, M; Henriksson, R; et al.

Protein expression in experimental malignant glioma varies over time and is altered by radiotherapy treatment

British Journal of Cancer, Vol. 94, (12) : 1853-1863

Wibom, Carl; Pettersson, Fredrik; Sjöström, Michael; et al.

Genetic variants in EGF, EGFR, ERBB₂, LRIG₂, LRIG₃ and meningioma risk

Ghasimi, Soma; Wibom, Carl; Brännström, Thomas; et al.

Genetic risk variants in the EGFR regions are associated with copy number variation in the EGFR gene as well as IDH₁, and p53 protein expression

Ghasimi, Soma; Wibom, Carl; Dahlin, Anna; et al.

Visa publikationer i DiVA

Forskargrupper

Gruppmedlem

Beatrice Melin

Forskningsprojekt

1 september 2023

SPRINTR